UXI:NYE-ProShares Ultra Industrials (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 33.5962

Change

+0.27 (+0.80)%

Market Cap

N/A

Volume

1.20K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.05 (-0.41%)

USD 8.14B
QLD ProShares Ultra QQQ

-0.04 (-0.05%)

USD 5.50B
SSO ProShares Ultra S&P500

+0.10 (+0.13%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

+0.14 (+0.21%)

USD 2.91B
TECL Direxion Daily Technology Bull..

-0.21 (-0.39%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

-0.01 (-0.03%)

USD 1.19B
USD ProShares Ultra Semiconductors

-0.94 (-2.37%)

USD 0.61B
UDOW ProShares UltraPro Dow30

+0.61 (+0.84%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

+2.22 (+4.03%)

USD 0.53B

ETFs Containing UXI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.58% 58% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.58% 58% F 30% F
Trailing 12 Months  
Capital Gain 1.62% 57% F 52% F
Dividend Return 0.16% 6% D- 2% F
Total Return 1.78% 55% F 40% F
Trailing 5 Years  
Capital Gain 146.29% 72% C 86% B+
Dividend Return 1.62% 8% B- 3% F
Total Return 147.91% 70% C- 83% B
Average Annual (5 Year Horizon)  
Capital Gain -9.21% 10% F 8% B-
Dividend Return -9.04% 10% F 6% D-
Total Return 0.17% 11% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 46.31% 71% C- 18% F
Risk Adjusted Return -19.52% 12% F 12% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.